alexa Modelling Treatment Response Could Reduce Virological F
ISSN 2155-6113

Journal of AIDS & Clinical Research
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Modelling Treatment Response Could Reduce Virological Failure in Different Patient Populations

Andrew D Revell1*, Dechao Wang1, Gabriella d’Ettorre2, Frank DE Wolf3, Brian Gazzard4, Giancarlo Ceccarelli5, Jose Gatell6, María Jésus Pérez-elías7, Vincenzo Vullo8, Julio S Montaner9, H Clifford Lane10 and Brendan A Larder1

1The HIV Resistance Response Database Initiative (RDI), London, UK

2Policlinico Umberto I, Rome, Italy

3Netherlands HIV Monitoring Foundation, Amsterdam, The Netherlands

4Chelsea and Westminster Hospital, London, UK

5Italian Red Cross, Rome, Italy

6Hospital Clinic of Barcelona, Barcelona, Spain

7Ramón y Cajal Hospital, Madrid, Spain

8University of Rome Sapienza, Rome, Italy

9BC Centre for Excellence in HIV/AIDS, Vancouver, Canada

10National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA

*Corresponding Author:
Andrew D. Revell, Ph.D
The HIV Resistance Response Database Initiative (RDI)
London, UK
Tel: +442072267314
Fax: +442072267314
E-Mail: [email protected]

Received Date: May 22, 2012; Accepted Date: July 05, 2012; Published Date: July 07, 2012

Citation: Revell AD, Wang D, d’Ettorre GD, Wolf FDE, Gazzard B, et al (2012) Modelling Treatment Response Could Reduce Virological Failure in Different Patient Populations. J AIDS Clinic Res S5:008. doi:10.4172/2155-6113.S5-008

Copyright: © 2012 Revell AD, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Background: HIV drug resistance can cause viral re-bound in patients on combination antiretroviral therapy, requiring a change in therapy to re-establish virological control. The RDI has developed computational models that predict response to combination therapy based on the viral genotype, viral load, CD4 count and treatment history. Here we compare two sets of models developed with different levels of treatment history information and test their generalisability to new patient populations.

Methods: Two sets of five random forest models were trained to predict the probability of virological response (follow-up viral load <50 copies/ml viral RNA) following a change in antiretroviral therapy using the baseline viral load, CD4 count, genotype and treatment history from 7,263 treatment change episodes. One set used six treatment history variables and the other 18 - one for each drug. The accuracy of the models was assessed in terms of the area under the receiver-operator characteristic curve (AUC) during cross validation and with 375 TCEs from clinics that had not contributed data to the training set.

Results: The mean AUC achieved by the two sets of models during cross validation was 0·815 and 0.820. Mean overall accuracy was 75% and 76%, sensitivity 64% and 62% and specificity 81% and 84%. The AUC for each committee tested with the independent test set was 0.87 and 0.855. Mean overall accuracy was 89% and 87%, sensitivity 67% and 61% and specificity 90% and 87%. There were no significant differences between the two sets. The models correctly predicted 330 (92%) of the 357 treatment failures observed in practice and were able to identify alternative regimens that were predicted to be effective for up to 267 (75%) of the failures and regimens with a higher probability of response for all cases.

Conclusions: Computational models can predict accurately the virological response to antiretroviral therapy from a range of variables including genotype and treatment history even for patients from unfamiliar settings. This approach has potential utility as a useful aid to treatment decision-making and may reduce treatment failure

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords